干旱区生态环境知识资源中心(Arid): Early and durable symptom control in patients with moderately to severely active ulcerative colitis treated with etrasimod (APD334) in the randomized, double-blind, placebo-controlled, Phase II OASIS trial and open label extension

Arid

	Early and durable symptom control in patients with moderately to severely active ulcerative colitis treated with etrasimod (APD334) in the randomized, double-blind, placebo-controlled, Phase II OASIS trial and open label extension
	Chiorean, M.; Vermeire, S.; Panes, J.; Peyrin-Biroulet, L.; Zhang, J.; Sands, B. E.; Cabell, C. H.; Naik, S. U.; Sandborn, W. J.
来源期刊	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
ISSN	0815-9319
EISSN	1440-1746
出版年	2020
卷号	35 页码:116-116
类型	Meeting Abstract
语种	英语
收录类别	SCI-E
WOS记录号	WOS:000589476200168
WOS类目	Gastroenterology & Hepatology
WOS研究方向	Gastroenterology & Hepatology
资源类型	期刊论文
条目标识符	http://119.78.100.177/qdio/handle/2XILL650/327519
作者单位	[Chiorean, M.] Virginia Mason Med Ctr, Div Gastroenterol, Seattle, WA 98101 USA; [Zhang, J.; Cabell, C. H.; Naik, S. U.] Univ Calif San Diego, Arena Pharmaceut, San Diego, CA 92103 USA; [Sands, B. E.] Icahn Sch Med Mt Sinai, New York, NY USA; [Vermeire, S.] Univ Hosp Leuven, Dept Gastroenterol, Leuven, Belgium; [Panes, J.] Hosp Clin Barcelona, IDIBAPS, CIBERehd, Barcelona, Spain; [Peyrin-Biroulet, L.] Lorraine Univ, IBD Unit, Dept Gastroenterol, Vandoeuvre Les Nancy, France
推荐引用方式 GB/T 7714	Chiorean, M.,Vermeire, S.,Panes, J.,et al. Early and durable symptom control in patients with moderately to severely active ulcerative colitis treated with etrasimod (APD334) in the randomized, double-blind, placebo-controlled, Phase II OASIS trial and open label extension[J],2020,35:116-116.
APA	Chiorean, M..,Vermeire, S..,Panes, J..,Peyrin-Biroulet, L..,Zhang, J..,...&Sandborn, W. J..(2020).Early and durable symptom control in patients with moderately to severely active ulcerative colitis treated with etrasimod (APD334) in the randomized, double-blind, placebo-controlled, Phase II OASIS trial and open label extension.JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY,35,116-116.
MLA	Chiorean, M.,et al."Early and durable symptom control in patients with moderately to severely active ulcerative colitis treated with etrasimod (APD334) in the randomized, double-blind, placebo-controlled, Phase II OASIS trial and open label extension".JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 35(2020):116-116.